NCT03449654View on ClinicalTrials.gov

Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

August 16, 2019

Study Completion Date

August 16, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Liraglutide

Liraglutid

DRUG

Placebo (for liraglutide)

Placebo (for liraglutide)

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
collaborator

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet & Cluster for Molecular Imaging, University of Copenhagen, Denmark

UNKNOWN

lead

Steno Diabetes Center Copenhagen

OTHER

NCT03449654 - Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes | Biotech Hunter | Biotech Hunter